Refetoff S, Weiss R E, Wing J R, Sarne D, Chyna B, Hayashi Y
Department of Medicine, University of Chicago, Illinois 60637.
Thyroid. 1994 Fall;4(3):249-54. doi: 10.1089/thy.1994.4.249.
Resistance to thyroid hormone (RTH) is a condition of impaired tissue responsiveness to thyroid hormone characterized by elevated free thyroid hormone levels in serum accompanied by nonsuppressed TSH. RTH has been associated with mutations in the thyroid hormone receptor (TR) beta gene. We report studies carried out in 9 members of a family (F94) of Jewish ethnic origin and a single subject of Mexican origin. All subjects fulfilling the criteria of RTH (6 of family F94 and one of family F27) had the same point mutation in the T3-binding domain on one of the two alleles of the TR beta gene. This mutation resulted in the replacement of the normal proline-453 with serine (P453S). Nevertheless, the clinical characteristics of affected members of each of the two families differed as did the severity of hormonal resistance in terms of responses to the administration of L-T3. Genetic studies indicate that the same mutation occurred independently in each of the two families.
甲状腺激素抵抗(RTH)是一种组织对甲状腺激素反应受损的病症,其特征是血清中游离甲状腺激素水平升高,同时促甲状腺激素(TSH)未被抑制。RTH与甲状腺激素受体(TR)β基因的突变有关。我们报告了对一个犹太裔家族(F94)的9名成员和一名墨西哥裔个体进行的研究。所有符合RTH标准的受试者(F94家族的6名成员和F27家族的1名成员)在TRβ基因两个等位基因之一的T3结合域中具有相同的点突变。该突变导致正常的脯氨酸-453被丝氨酸取代(P453S)。然而,两个家族中受影响成员的临床特征不同,对L-T3给药反应的激素抵抗严重程度也不同。基因研究表明,相同的突变在两个家族中各自独立发生。